Pharmacotherapy Booklet |
Heart attack warning signs |
Primary Coronary Angioplasty DelayImpact
of primary coronary angioplasty delay on myocardial salvage, infarct size and
microvascular damage in patients with ST-segment elevation myocardial
infarction: Insight from magnetic resonance. Authors: Francone MC, Bucciarelli-Ducci C, Carbone I, et al. To access the article, click here |
The Impact of Cardiac RehabilitationThe
impact of cardiac rehabilitation and secondary prevention programs on 12-month clinical
outcomes: A linked data analysis. To access the article, click here |
Exercise‐based cardiac rehabilitation for coronary heart diseaseExercise-based
cardiac rehabilitation for coronary heart disease Authors: Anderson
L, Thompson DR, Oldridge N, et al To access the article, click here |
Heart Foundation - Heart MapsThe Heart Foundation Heart Maps allow you to take a closer look at heart disease indicators across Australia. You can see how state, region, or local governments compare for:
At a state/territory and regional level you can drill further into the specific types of heart-related hospitalisations. These includes rates for; acute coronary syndrome, atrial fibrillation, coronary heart disease, heart attack, heart failure, rhythm, and valve disease admissions, as well as the higher level classifications of cardiovascular disease and coronary heart disease. Click the image to access the Heart Maps |
Patients want to know about 'cardiac blues'Patients want to know about the ‘cardiac blues’ The aim of this study was to investigate patients’ preferences regarding information provision about cardiac blues. To access the article, click here |
Healing the heart after an acute cardiac eventHealing
the heart after an acute cardiac event Article published in InPsych Authors: Murphy
B, Higgins R, Clarke J, Rogerson M, Jackson A To access the article, click here |
Dyslipidaemia managementManagement of dyslipidaemia in patients with type 2 diabetes in Australian primary care The objective of this research was to examine the frequency of dyslipidaemia and treatment with lipid-lowering drugs in patients with type 2 diabetes managed in Australian primary care. To access the article, click here |
Diabetes: the silent pandemic and its impact on AustraliaArticle from the Heart
and Diabetes Institute. Diabetes: the silent pandemic and its impact on
Australia. Edited by Associate Professor Jonathan Shaw, Associate Director, Baker IDI Heart and Diabetes Institute and Stephanie Tanamas,
Epidemiologist, Baker IDI Heart and Diabetes Institute, with input from Diabetes Australia and Juvenile Diabetes Research
Foundation (JDRF) To access the article, click the image. |